Medication use and risk of amyotrophic lateral sclerosis—a systematic review
Abstract Background Studying whether medications act as potential risk factors for amyotrophic lateral sclerosis (ALS) can contribute to the understanding of disease etiology as well as the identification of novel therapeutic targets. Therefore, we conducted a systematic review to summarize the exis...
Main Authors: | Can Cui, Jiangwei Sun, Kyla A. McKay, Caroline Ingre, Fang Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-022-02442-w |
Similar Items
-
Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis
by: Can Cui, et al.
Published: (2022-03-01) -
Depression in amyotrophic lateral sclerosis
by: Joanna Iłżecka
Published: (2021-10-01) -
Amyotrophic lateral sclerosis : advances and perspectives of neuronanomedicine /
by: Machtoub, Lina, author, et al.
Published: (2016) -
Incidence, prevalence, and medical expenditures of classical amyotrophic lateral sclerosis in Taiwan, 1999–2008
by: Ching-Piao Tsai, et al.
Published: (2015-07-01) -
Progress in clinical diagnosis of amyotrophic lateral sclerosis
by: Qiong YANG, et al.
Published: (2012-06-01)